← Back to Search

Corticosteroid

Cervical Pain for 6 months or less and scheduled for TFESI for Herniated Disc

Phase 4
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks, 3 months, 12 months
Awards & highlights

Study Summary

This trial is examining the effects of a cervical transforaminal steroid injection on pain and function.

Eligible Conditions
  • Herniated Disc
  • Cervical Radiculopathy
  • Cervical Spondylosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks, 3 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks, 3 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
50% or less improvement in index pain
50-79% improvement in index pain
80% or greater improvement in index pain

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cervical Pain for 6 months or less and scheduled for TFESIExperimental Treatment1 Intervention
Participants who meet inclusion and exclusion criteria will be enrolled into the study after consenting to and before receiving a first cervical TFESI. The baseline examination and all baseline questionnaires will be completed within 2 weeks before the first cervical TFESI. Participants will be given a daily pain diary chart to record NRS and percentage improvement during the 1st month post-injection. Participants will be contacted in the 1st week post-injection with a standardized questionnaire about their symptoms and a reminder about the 4 week (+/- 1 week) post-injection follow up. Routine scheduled follow-up by clinic visit or telephone call will occur at 4 weeks (+/- 1 week), 8 weeks (+/- 2 weeks), 3 months (+/- 2 weeks), 6 months (+/- 1 month), and 12 months (+/- 1 month), at which times all follow-up measures will be obtained.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,094 Previous Clinical Trials
1,775,488 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor open to individuals aged 35 and older?

"This medical trial has set the minimum age requirement of 18 years old and limits eligibility to those younger than 80."

Answered by AI

Is it possible to participate in this research initiative?

"Qualifying criteria for this medical trial mandates that candidates possess spondylosis, cervical issues, and are between 18 to 80 years of age. The study is recruiting a total of 29 participants."

Answered by AI

Are there still spots available for this experiment?

"This particular trial is no longer actively enrolling participants. It was first listed on October 23, 2018 and had its last update November 21st 2022. If you are seeking other research opportunities, there are presently 104 clinical trials examining spondylosis of the cervical region that are recruiting patients as well as 553 studies investigating this treatment option."

Answered by AI

Are there any alternative studies which have explored utilizing this therapeutic approach?

"At this time, there are 553 clinical trials underway related to the treatment in question; of those active studies, 144 have reached Phase 3. While most tests occur within Mishawaka, Indiana, 18618 locations around the world are conducting examination as well."

Answered by AI

What conditions have been known to respond positively to this treatment?

"Ophthalmia and sympathetic oculi are the primary conditions that this therapeutic approach aims to treat. Additionally, it can be utilized to combat eye issues such as branch retinal vein occlusion and macular edema."

Answered by AI

How many participants have enrolled in this experiment?

"This clinical trial is no longer in the recruitment phase. The initial post was made on October 23, 2018 and it's last update was November 21, 2022. If you are looking for alternative trials to participate in, there currently exist 104 active studies aimed at spondylosis patients as well as 553 trials related to this treatment with enrolment still open."

Answered by AI

What associated hazards might be encountered with this particular treatment?

"This treatment has exhibited a high degree of safety, especially due to its Phase 4 status which indicates an approval from regulatory bodies. As such, it was given a 3 on the risk scale."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Effectiveness of Cervical Transforaminal Epidural Steroid Injection
Zack McCormick 2018. "Effectiveness of Cervical Transforaminal Epidural Steroid Injection". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04544683.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top